Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
iBio, Inc.Listing on record | Sell | $2.6M | SEC | ||
iBio, Inc.Listing on record | Sell | $4M | SEC | ||
iBio, Inc.Listing on record | Sell | $11.6M | SEC | ||
iBio, Inc.Listing on record | Buy | $1.5M | conv 61First in 12mo | SEC | |
iBio, Inc.Listing on record | BuyD (derivative) | $5.8M | First in 12mo | SEC | |
Marker Therapeutics, Inc.Listing on record | Other | $2.5M | SEC | ||
Marker Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Marker Therapeutics, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Marker Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
iBio, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
iBio, Inc.Listing on record | Buy | $2.2M | conv 52First in 12mo | SEC | |
iBio, Inc.Listing on record | Other | $945.5K | Unusual size | SEC | |
Vericel CorpListing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Vericel CorpListing on record | Other | $1.7M | SEC | ||
iBio, Inc.Listing on record | OtherD (derivative) | $3M | SEC | ||
iBio, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
iBio, Inc.Listing on record | Other | $3M | SEC | ||
iBio, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |